Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Hematology

Building Your Care Team and Daily Life

At a Glance

People with familial thrombomodulin anomalies should have a hematologist-led team that understands both bleeding and clotting risks. Written plans before surgery or pregnancy, coordinated specialist care, and close postpartum monitoring help prepare for emergencies and flares.

Because familial thrombomodulin anomalies are so rare, you cannot rely on a single doctor to manage every aspect of your care. Most general physicians will never have seen this condition, and even specialists may only have managed one or two cases in their careers [1]. Managing this condition effectively requires a “multidisciplinary” team—a group of experts who talk to each other to prevent one treatment from causing a problem in another part of your body [2][3].

Assembling Your Expert Team

The “captain” of your care team should be a hematologist who specializes in hemostasis and thrombosis (the study of how blood clots and bleeds) [2]. Look for a clinician or center with relevant bleeding, thrombosis, complement, and genetics expertise.

Depending on your symptoms, your team should also include:

  • Nephrologist: Essential if you have the clotting/aHUS phenotype. They monitor your kidney function and manage treatments like C5 inhibitors [3][4].
  • Medical Geneticist or Genetic Counselor: They help interpret your specific THBD variant and coordinate testing for family members [5][1].
  • Maternal-Fetal Medicine (MFM) Specialist: If you are planning a pregnancy, an MFM specialist (a high-risk OB-GYN) is required to manage the unique risks of the mutation for both you and the baby [6][7].

Navigating High-Risk Triggers

Certain events act as “stress tests” for your blood vessels and can trigger a bleeding or clotting crisis.

Surgery and Major Trauma

Standard surgical protocols are often not enough for THBD patients. Because routine clotting tests (PT/aPTT) may look normal even when you are at risk, your team must create a “Perioperative Hemostasis Plan” before any elective procedure [8][9].

  • Specialized Testing: A written plan should specify the confirmed diagnosis, medications to consider or avoid, and on-call specialist. While specialized testing like thrombin generation assays may be useful long-term [1][10], they are not required before emergency stabilization.
  • Product Planning: The hospital’s blood bank must be alerted in advance. If you have the bleeding type (TM-AC), standard “clotting factor” infusions may only be partially effective, and your team will direct the specialist use of hemostatic medications or blood products based on your proven phenotype [10][11].

Pregnancy and Childbirth

Pregnancy is a significant trigger for the clotting/aHUS phenotype and a major risk for those with the bleeding phenotype [6][12].

  • Pre-conception Planning: You should meet with your hematologist and an MFM specialist before getting pregnant to discuss if your current medications need to change.
  • Delivery Coordination: Depending on your specific variant, phenotype, and kidney status, delivery may need to take place at a hospital equipped with intensive care [13][14].
  • Postpartum Monitoring: The postpartum period requires individualized observation as it can be a risk window for flares [15][16]. You will likely need very frequent blood and urine checks during this window.

Evaluating Your Care Team

Since you may be more familiar with your condition than some of your providers, it is important to “vet” your specialists. A qualified team should:

  1. Acknowledge the rarity: They should be honest about the lack of universal protocols and willing to consult with national experts or academic research centers [2].
  2. Focus on the “phenotype”: They should ask whether your specific mutation is a “gain-of-function” (bleeding) or “loss-of-function” (clotting) variant [17][18].
  3. Provide a written plan: For any surgery or pregnancy, you should receive a clear, step-by-step document that you can show to an emergency room doctor if you are seen somewhere else [7].

If you find that your local hospital is uncomfortable managing your case, you can ask for a referral to a Comprehensive Hemophilia Treatment Center (HTC) or an academic TMA/aHUS Center of Excellence. These centers have the specialized laboratories and multidisciplinary teams required to handle rare thrombomodulin anomalies safely.

Common questions in this guide

Which specialist should coordinate care for familial thrombomodulin anomalies?
A hematologist with expertise in bleeding and clotting disorders should usually coordinate the care team. Depending on your health needs, a kidney specialist, genetics professional, and high-risk pregnancy specialist may also be involved.
Why do I need more than one specialist for a THBD disorder?
THBD variants can be associated with either bleeding or excessive clotting, and care may involve blood, kidneys, genetics, and pregnancy planning. A coordinated team helps one treatment or procedure avoid creating problems elsewhere.
What should be included in my plan before surgery?
Before planned surgery, ask for a written bleeding-and-clotting plan that states your diagnosis, bleeding or clotting pattern, medicines to use or avoid, and who to contact. The hospital blood bank and surgical team should know about the condition in advance because routine PT and aPTT clotting tests may look normal even when special precautions are needed.
How should pregnancy be planned with a familial thrombomodulin anomaly?
Meet with your hematologist and a maternal-fetal medicine specialist before trying to conceive so they can review medicines and risks for you and the baby. Depending on your variant and kidney health, delivery may need a hospital with intensive care, followed by close blood and urine monitoring after birth.
Are specialized tests needed during an emergency?
Specialized tests such as thrombin generation or soluble thrombomodulin testing may help with long-term evaluation, but emergency stabilization should not wait for them. The treating team should use your known diagnosis and bleeding or clotting history while contacting an experienced specialist.
Where can I find specialized care for this rare condition?
Ask for a referral to a Comprehensive Hemophilia Treatment Center or an academic center experienced with thrombotic microangiopathy and aHUS. These centers may have specialized laboratories and teams familiar with rare bleeding, clotting, kidney, and genetic problems.

Get notified when new evidence is published on Familial thrombomodulin anomalies.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (18)
  1. 1

    A new pedigree with thrombomodulin-associated coagulopathy in which delayed fibrinolysis is partially attenuated by co-inherited TAFI deficiency.

    Westbury SK, Whyte CS, Stephens J, et al.

    Journal of thrombosis and haemostasis : JTH 2020; (18(9)):2209-2214 doi:10.1111/jth.14990.

    PMID: 32634856
  2. 2

    How to investigate mild to moderate bleeding disorders and bleeding disorder of unknown cause.

    Casini A, Gebhart J

    International journal of laboratory hematology 2024; (46 Suppl 1()):27-33 doi:10.1111/ijlh.14266.

    PMID: 38454298
  3. 3

    Thrombotic microangiopathy without renal involvement: two novel mutations in complement-regulator genes.

    Peyvandi F, Rossio R, Ferrari B, et al.

    Journal of thrombosis and haemostasis : JTH 2016; (14(2)):340-5 doi:10.1111/jth.13210.

    PMID: 26613809
  4. 4

    Nephrotic-Range Proteinuria and Peripheral Edema in a Child: Not Only Idiopathic Nephrotic Syndrome.

    Dolcemascolo V, Vivarelli M, Colucci M, et al.

    Case reports in nephrology and dialysis 2016; (6(3)):120-127 doi:10.1159/000449423.

    PMID: 27904864
  5. 5

    Routine use of clinical exome-based next-generation sequencing for evaluation of patients with thrombotic microangiopathies.

    Gaut JP, Jain S, Pfeifer JD, et al.

    Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2017; (30(12)):1739-1747 doi:10.1038/modpathol.2017.90.

    PMID: 28752844
  6. 6

    Atypical Hemolytic Uremic Syndrome in a Pregnant Patient with a Thrombomodulin Gene Variant Treated with Plasma Exchange and Eculizumab.

    Kannan L

    The American journal of case reports 2023; (24()):e938896 doi:10.12659/AJCR.938896.

    PMID: 37120715
  7. 7

    Updated Australian consensus statement on management of inherited bleeding disorders in pregnancy.

    Dunkley S, Curtin JA, Marren AJ, et al.

    The Medical journal of Australia 2019; (210(7)):326-332 doi:10.5694/mja2.50123.

    PMID: 30924538
  8. 8

    Society for Perioperative Assessment and Quality Improvement: a narrative review of best practices for perioperative management of patients with bleeding disorders.

    Khambaty M, Connors JM, Grawe ES, et al.

    British journal of anaesthesia 2025; (135(5)):1269-1278 doi:10.1016/j.bja.2025.07.090.

    PMID: 41027819
  9. 9

    Bleeding Risk Assessment and Management Strategies for Elective Surgery and Invasive Procedures: A Systematic Review.

    Alsagga H, Bassiony MI, Eladani OMB, et al.

    Cureus 2026; (18(5)):e108286 doi:10.7759/cureus.108286.

    PMID: 42255763
  10. 10

    Altered fibrinolysis in autosomal dominant thrombomodulin-associated coagulopathy.

    Burley K, Whyte CS, Westbury SK, et al.

    Blood 2016; (128(14)):1879-1883 doi:10.1182/blood-2016-05-716092.

    PMID: 27436851
  11. 11

    Surgery in rare bleeding disorders: the prospective MARACHI study.

    Rousseau F, Guillet B, Mura T, et al.

    Research and practice in thrombosis and haemostasis 2023; (7(7)):102199 doi:10.1016/j.rpth.2023.102199.

    PMID: 37867585
  12. 12

    Present day management of inherited bleeding disorders in pregnancy.

    Kouides PA

    Expert review of hematology 2016; (9(10)):987-95 doi:10.1080/17474086.2016.1216312.

    PMID: 27459638
  13. 13

    Von Willebrand Disease, Hemophilia, and Other Inherited Bleeding Disorders in Pregnancy.

    Pacheco LD, Saade GR, James AH

    Obstetrics and gynecology 2023; (141(3)):493-504 doi:10.1097/AOG.0000000000005083.

    PMID: 36800851
  14. 14

    Management of pregnant women who have bleeding disorders.

    James AH, Pacheco LD, Konkle BA

    Hematology. American Society of Hematology. Education Program 2023; (2023(1)):229-236 doi:10.1182/hematology.2023000475.

    PMID: 38066866
  15. 15

    Primary postpartum haemorrhage in women with von Willebrand disease or carriership of haemophilia despite specialised care: a retrospective survey.

    Stoof SC, van Steenbergen HW, Zwagemaker A, et al.

    Haemophilia : the official journal of the World Federation of Hemophilia 2015; (21(4)):505-12 doi:10.1111/hae.12635.

    PMID: 25688733
  16. 16

    Hematologic Findings in Pregnancy: A Guide for the Internist.

    Patel P, Balanchivadze N

    Cureus 2021; (13(5)):e15149 doi:10.7759/cureus.15149.

    PMID: 34164247
  17. 17

    Laboratory diagnosis of congenital and acquired coagulopathies, including challenging-to-diagnose rare bleeding disorders.

    Al Dawood R, Hayward CPM

    Pathology 2025; (57(6)):687-695 doi:10.1016/j.pathol.2025.06.004.

    PMID: 40796410
  18. 18

    Rare inherited coagulation and fibrinolytic defects that challenge diagnostic laboratories.

    Mathews N, Tasneem S, Hayward CPM

    International journal of laboratory hematology 2023; (45 Suppl 2()):30-43 doi:10.1111/ijlh.14084.

    PMID: 37211424

This information about organizing care for familial thrombomodulin anomalies is for informational purposes only and does not replace medical advice. Your hematologist and other specialists should create an individualized plan for surgery, pregnancy, medications, and emergencies.